Free Trial

Oxbridge Re (OXBR) Competitors

Oxbridge Re logo
$2.04 -0.06 (-2.86%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$2.04 +0.00 (+0.20%)
As of 07/25/2025 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OXBR vs. NEUE, AAME, ZBAO, HUIZ, FGF, AIFU, CNFR, TIRX, XHG, and ACGLO

Should you be buying Oxbridge Re stock or one of its competitors? The main competitors of Oxbridge Re include NeueHealth (NEUE), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), Fundamental Global (FGF), AIFU (AIFU), Conifer (CNFR), Tian Ruixiang (TIRX), XChange TEC.INC. (XHG), and Arch Capital Group (ACGLO). These companies are all part of the "insurance" industry.

Oxbridge Re vs. Its Competitors

NeueHealth (NYSE:NEUE) and Oxbridge Re (NASDAQ:OXBR) are both small-cap insurance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

In the previous week, Oxbridge Re had 2 more articles in the media than NeueHealth. MarketBeat recorded 3 mentions for Oxbridge Re and 1 mentions for NeueHealth. NeueHealth's average media sentiment score of 0.00 beat Oxbridge Re's score of -0.04 indicating that NeueHealth is being referred to more favorably in the media.

Company Overall Sentiment
NeueHealth Neutral
Oxbridge Re Neutral

NeueHealth presently has a consensus target price of $7.00, indicating a potential upside of 3.09%. Oxbridge Re has a consensus target price of $5.00, indicating a potential upside of 145.10%. Given Oxbridge Re's stronger consensus rating and higher probable upside, analysts plainly believe Oxbridge Re is more favorable than NeueHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeueHealth
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Oxbridge Re
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NeueHealth has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Oxbridge Re has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500.

Oxbridge Re has lower revenue, but higher earnings than NeueHealth. Oxbridge Re is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeueHealth$936.66M0.06-$134.68M-$22.00-0.31
Oxbridge Re$550K27.60-$2.73M-$0.30-6.80

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are held by institutional investors. 63.3% of NeueHealth shares are held by company insiders. Comparatively, 19.5% of Oxbridge Re shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

NeueHealth has a net margin of -14.28% compared to Oxbridge Re's net margin of -143.80%. NeueHealth's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company Net Margins Return on Equity Return on Assets
NeueHealth-14.28% N/A -17.46%
Oxbridge Re -143.80%-41.78%-23.85%

Summary

NeueHealth and Oxbridge Re tied by winning 8 of the 16 factors compared between the two stocks.

Get Oxbridge Re News Delivered to You Automatically

Sign up to receive the latest news and ratings for OXBR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OXBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OXBR vs. The Competition

MetricOxbridge ReINS IndustryFinance SectorNASDAQ Exchange
Market Cap$15.63M$26.50B$12.28B$9.50B
Dividend YieldN/A1.14%5.54%4.01%
P/E Ratio-6.8037.3719.0320.05
Price / Sales27.604.8126.1090.07
Price / CashN/A32.2021.6358.56
Price / Book3.004.922.205.87
Net Income-$2.73M$835.86M$997.25M$258.55M
7 Day Performance-11.69%1.73%0.60%3.74%
1 Month Performance15.91%2.97%3.44%11.75%
1 Year Performance-32.23%-5.13%536.57%18.03%

Oxbridge Re Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OXBR
Oxbridge Re
2.1291 of 5 stars
$2.04
-2.9%
$5.00
+145.1%
-40.4%$15.63M$550K-6.803
NEUE
NeueHealth
0.7921 of 5 stars
$6.84
+0.4%
$7.00
+2.4%
+13.0%$60.80M$936.66M-0.311,252News Coverage
AAME
Atlantic American
0.9172 of 5 stars
$2.24
+3.2%
N/A+38.8%$44.36M$191.36M-24.89140
ZBAO
Zhibao Technology
N/A$0.99
-2.9%
N/A-73.6%$32.15M$25.27M0.00148
HUIZ
Huize
0.8969 of 5 stars
$2.67
-4.6%
$2.30
-13.9%
-89.2%$28.25M$171.10M-6.361,640Positive News
Gap Down
FGF
Fundamental Global
2.8437 of 5 stars
$27.98
+52.1%
N/A-19.7%$23.41M$17.35M21.369Positive News
Gap Up
High Trading Volume
AIFU
AIFU
N/A$6.78
-4.5%
N/AN/A$20.56M$247.81M9.294,707Positive News
CNFR
Conifer
2.4571 of 5 stars
$0.92
+5.9%
N/A+3.0%$10.67M$67.27M0.47150Positive News
TIRX
Tian Ruixiang
1.8265 of 5 stars
$1.08
-4.5%
N/A-51.4%$820K$3.22M0.0050
XHG
XChange TEC.INC.
N/A$1.34
+0.8%
N/AN/A$20K$41.09M0.0030Positive News
ACGLO
Arch Capital Group
N/A$20.68
+0.3%
N/A-8.0%$0.00$17.64B0.005,200Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:OXBR) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners